Is aplastic osteodystrophy a disease of malnutrition?

被引:27
作者
Fukagawa, M
Akizawa, T
Kurokawa, K
机构
[1] Kobe Univ, Sch Med, Div Dialysis & Metab, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Wakayama Sch Med, Wakayama, Japan
[3] Tokai Univ, Sch Med, Kanagawa 2591100, Japan
关键词
D O I
10.1097/00041552-200007000-00007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Adynamic bone disease is emerging as a major type of renal osteodystrophy in chronic dialysis patients. Relative hypoparathyroidism is one of the important abnormalities underlying this disease. Recently, several reports have suggested that hypoparathyroidism reflects, at least in part, a state of malnutrition and contributes to the poor prognosis of patients on hemodialysis and chronic ambulatory peritoneal dialysis. Such a risk of survival may result not only from the malnutritional state, but also from unknown mechanisms resulting from parathyroid hormone (PTH) deficiency, or from other abnormalities that suppress PTH secretion. Another major abnormality underlying adynamic bone disease is the skeletal resistance to PTH in patients with uremia. Owing to the recent research on bone turnover at the molecular level, several new mechanisms for this abnormality have been elucidated. Correction of this 'skeletal resistance to PTH' will lead to the optimal management of parathyroid function and bone turnover in the future. Curr Opin Nephrol Hypertens 9:363-367. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 65 条
  • [1] Akizawa T, 1997, KIDNEY INT, V52, pS72
  • [2] Akizawa T., 1998, Journal of the American Society of Nephrology, V9, p561A
  • [3] AKIZAWA T, 1999, J AM SOC NEPHROL, V10, pA616
  • [4] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
    Anderson, DM
    Maraskovsky, E
    Billingsley, WL
    Dougall, WC
    Tometsko, ME
    Roux, ER
    Teepe, MC
    DuBose, RF
    Cosman, D
    Galibert, L
    [J]. NATURE, 1997, 390 (6656) : 175 - 179
  • [5] IDENTIFICATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF OSTEOBLAST MITOGENESIS IN UREMIC PLASMA
    ANDRESS, DL
    HOWARD, GA
    BIRNBAUM, RS
    [J]. KIDNEY INTERNATIONAL, 1991, 39 (05) : 942 - 945
  • [6] Risk factors for vertebral fractures in renal osteodystrophy
    Atsumi, K
    Kushida, K
    Yamazaki, K
    Shimizu, S
    Ohmura, A
    Inoue, T
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (02) : 287 - 293
  • [7] Avram M. M., 1999, Journal of the American Society of Nephrology, V10, p311A
  • [8] Avram M. M., 1999, Journal of the American Society of Nephrology, V10, p272A
  • [9] Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia
    Avram, MM
    Sreedhara, R
    Avram, DK
    Muchnick, RA
    Fein, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) : 924 - 930
  • [10] Frequency of adynamic bone disease and aluminium storage in Italian uraemic patients - Retrospective analysis of 1429 iliac crest biopsies
    Ballanti, P
    Wedard, BM
    Bonucci, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (04) : 663 - 667